CELATOR PHARMACEUTICALS INC - COM (CPXX)

CUSIP: 15089R102

Q3 2015 13F Holders as of 30 Sep 2015

Type / Class
Equity / COM
Total 13F shares
3,150,124
Share change
+240,790
Total reported value
$5,229,000
Price per share
$1.66
Number of holders
16
Value change
+$362,756
Number of buys
10
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP 15089R102?
CUSIP 15089R102 identifies CPXX - CELATOR PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CELATOR PHARMACEUTICALS INC - COM (CPXX) as of Q3 2015

As of 30 Sep 2015, CELATOR PHARMACEUTICALS INC - COM (CPXX) was held by 16 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,150,124 shares. The largest 10 holders included CAXTON CORP, VANGUARD GROUP INC, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Fund Advisors, GOLDMAN SACHS GROUP INC, BlackRock Institutional Trust Company, N.A., TFS CAPITAL LLC, Bank of New York Mellon Corp, and NORTHERN TRUST CORP. This page lists 16 institutional shareholders reporting positions in this security for the Q3 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.